Zobrazeno 1 - 10
of 1 377
pro vyhledávání: '"Loscertales, J"'
Autor:
Mateu-Albero T; Immunology Department, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Instituto Princesa (IIS-IP), Madrid, Spain., Marcos-Jimenez A; Immunology Department, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Instituto Princesa (IIS-IP), Madrid, Spain., Delgado-Wicke P; IMMED S.L., Immunological and Medicinal Products, Madrid, Spain., Terrón F; IMMED S.L., Immunological and Medicinal Products, Madrid, Spain.; Catapult Therapeutics, Lelystad, The Netherlands., Loscertales J; Hematology Department, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Instituto Princesa (IIS-IP), Madrid, Spain., López-Matencio JMS; Pharmacy Department, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Instituto Princesa (IIS-IP), Madrid, Spain., Muñoz-Calleja C; Immunology Department, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Instituto Princesa (IIS-IP), Madrid, Spain.; Immunology Department, Medicine Faculty, Universidad Autónoma de Madrid, Madrid, Spain., Cuesta-Mateos C; Immunology Department, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Instituto Princesa (IIS-IP), Madrid, Spain.; IMMED S.L., Immunological and Medicinal Products, Madrid, Spain.; Catapult Therapeutics, Lelystad, The Netherlands.
Publikováno v:
Hematological oncology [Hematol Oncol] 2023 Dec; Vol. 41 (5), pp. 869-876. Date of Electronic Publication: 2023 Aug 07.
Autor:
Al-Sawaf O; University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany., Robrecht S; University Hospital of Cologne, Köln, Germany., Zhang C; University of Cologne, Faculty of Medicine and University Hospital Cologne, Köln, Germany., Olivieri S; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Chang YM; F. Hoffmann-La Roche Ltd, Mississauga, Canada., Fink AM; University Hospital of Cologne, Cologne, Germany., Tausch E; Ulm University, Ulm, Germany., Schneider C; Ulm University, Ulm, Germany., Ritgen M; University Clinic of Schleswig-Holstein, Kiel, Kiel, Germany., Kreuzer KA; University at Cologne, Cologne, Germany., Sivcheva L; Multiprofile Hospital for Active Treatment Pazardjik, Bulgaria., Niemann CU; Rigshospitalet, Copenhagen Ø, Denmark., Schwarer AP; Box Hill Hospital, Melbourne, Australia., Loscertales J; Hospital Universitario de La Princesa, Madrid, Spain., Weinkove R; Cancer Immunotherapy Programme, Malaghan Institute of Medical Research, New Zealand., Strumberg D; Evangelisches Krankenhaus - Herne, Germany., Kilfoyle A; Palmerston North Hospital, Palmerston North, New Zealand., Manzoor BS; AbbVie Inc, United States., Jawaid D; AbbVie Inc, North Chicago, Illinois, United States., Emechebe N; AbbVie Inc, North Chicago, Illinois, United States., Devine J; Genentech Inc., South San Francisco, California, United States., Boyer M; F. Hoffmann-La Roche Ltd, Welwyn Garden City, United Kingdom., Runkel ED; AbbVie Inc, Mettawa, Illinois, United States., Eichhorst B; University of Cologne, Cologne, Germany., Stilgenbauer S; Ulm University, Ulm, Germany., Jiang Y; Genentech, Inc., South San Francisco, California, United States., Hallek MJ; University of Cologne, Cologne, Germany., Fischer K; University Hospital Cologne, Cologne, Germany.
Publikováno v:
Blood [Blood] 2024 Jul 10. Date of Electronic Publication: 2024 Jul 10.
Autor:
Casado LF, Burgos A, González-Haba E, Loscertales J, Krivasi T, Orofino J, Rubio-Terres C, Rubio-Rodríguez D
Publikováno v:
ClinicoEconomics and Outcomes Research, Vol Volume 8, Pp 475-484 (2016)
Luis Felipe Casado,1 Amparo Burgos,2 Eva González-Haba,3 Javier Loscertales,4 Tania Krivasi,5 Javier Orofino,6 Carlos Rubio-Terres,7 Darío Rubio-Rodríguez7 1Hematology Department, Hospital Virgen de la Salud, Toledo, Spain; 2Pharmacy Department, H
Externí odkaz:
https://doaj.org/article/ccb05eef5cdc42faa58d74f6c59fb067
Autor:
Loscertales J; Hematology Department, Hospital Universitario de la Princesa, Calle de Diego de León 62, 28006 Madrid, Spain., Abrisqueta-Costa P; Hematology Department, Hospital Universitari Vall d'Hebron, Pg de la vall d'Hebron 199, 08035 Barcelona, Spain., Gutierrez A; Hematology Department, Hospital Son Espases/IdISBa, Carretera de Valldemossa 79, 07120 Palma de Mallorca, Spain., Hernández-Rivas JÁ; Hematology Department, Hospital Universitario Infanta Leonor, Avda. Gran Vía del Este 80, 28031 Madrid, Spain., Andreu-Lapiedra R; Hematology Department, Hospital Universitario La Fe, Avinguda de Fernando Abril Martorell 106, 46026 Valencia, Spain., Mora A; Hematology Department, Hospital de la Santa Creu i Sant Pau, Calle de St. Antoni Maria Claret 167, 08025 Barcelona, Spain., Leiva-Farré C; Medical Department, Astrazeneca Farmacéutica Spain S.A., Calle del Puerto de Somport 21, 28050 Madrid, Spain., López-Roda MD; Medical Department, Astrazeneca Farmacéutica Spain S.A., Calle del Puerto de Somport 21, 28050 Madrid, Spain., Callejo-Mellén Á; Medical Department, Astrazeneca Farmacéutica Spain S.A., Calle del Puerto de Somport 21, 28050 Madrid, Spain., Álvarez-García E; Medical Department, Astrazeneca Farmacéutica Spain S.A., Calle del Puerto de Somport 21, 28050 Madrid, Spain., García-Marco JA; Hematology Department, Hospital Universitario Puerta de Hierro-Majadahonda, Calle Joaquín Rodrigo 1, 28222 Majadahonda, Spain.
Publikováno v:
Cancers [Cancers (Basel)] 2023 Aug 10; Vol. 15 (16). Date of Electronic Publication: 2023 Aug 10.
Autor:
Triviño, A., Cózar, F., Congregado, M., Gallardo, G., Moreno-Merino, S., Jiménez-Merchán, R., Loscertales, J.
Publikováno v:
In Cirugía Española (English Edition) December 2011 89(10):677-680
Autor:
Al‐Sawaf, O., Robrecht, S., Zhang, C., Olivieri, S., Chang, Y. M., Fink, A. M., Tausch, E., Schneider, C., Ritgen, M., Kreuzer, K., Sivcheva, L., Niemann, C., Schwarer, A., Loscertales, J., Weinkove, R., Strumberg, D., Kilfoyle, A., Runkel, E. D., Eichhorst, B., Stilgenbauer, S.
Publikováno v:
Hematological Oncology; Jun2023 Supplement 1, Vol. 41, p58-60, 3p
Autor:
Herishanu Y, Shaulov A, Fineman R, BasiC-Kinda S, Aviv A, Wasik-Szczepanek E, Jaksic O, Zdrenghea M, Greenbaum U, Mandac I, Simkovic M, Morawska M, Benjamini O, Spacek M, Nemets A, Bairey O, Trentin L, Ruchlemer R, Laurenti L, Ciocan O, Doubek M, Shvidel L, Dali N, Miras F, De Meuter A, Dimou M, Mauro F, Coscia M, Bumbea H, Szasz R, Tadmor T, Gutwein O, Gentile M, Scarfo L, Tedeschi A, Sportoletti P, Vazquez E, Marquet J, Assouline S, Papaioannou M, Braester A, Levato L, Gregor M, Rigolin G, Loscertales J, Perez A, Nijziel M, Popov V, Collado R, Slavutsky I, Itchaki G, Ringelstein S, Goldschmidt N, Perry C, Levi S, Polliack A, Ghia P
Publikováno v:
AMERICAN JOURNAL OF HEMATOLOGY
r-FIHGUV. Repositorio Institucional de Producción Científica de la Fundación de Investigación del Hospital General de Valencia
instname
r-FIHGUV. Repositorio Institucional de Producción Científica de la Fundación de Investigación del Hospital General de Valencia
instname
In recent years, considerable progress has been made in frontline therapy for elderly/physically unfit patients with CLL. The combination of obinutuzumab and chlorambucil (O-Clb) has been shown to prolong progression free survival (PFS, median PFS-31
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::807185497322b84d08591ef37660403b
https://fundanet.fihgu.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=1598
https://fundanet.fihgu.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=1598
We report follow-up results from the randomized, placebo-controlled, phase 3 HELIOS trial of ibrutinib+bendamustine and rituximab (BR) for previously treated chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) without deletion 17p. Ov
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::7d278515513371dfaf3993194805014e
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3077418
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3077418
Autor:
Mateu-Albero T; Immunology Department, Hospital Universitario de La Princesa, IIS-IP, 28006 Madrid, Spain., Marcos-Jimenez A; Immunology Department, Hospital Universitario de La Princesa, IIS-IP, 28006 Madrid, Spain.; Department of Oncology, Microbiology and Immunology, University of Fribourg, CH-1700 Freiburg, Switzerland., Wissmann S; Department of Oncology, Microbiology and Immunology, University of Fribourg, CH-1700 Freiburg, Switzerland., Loscertales J; Hematology Department, Hospital Universitario de La Princesa, IIS-IP, 28006 Madrid, Spain., Terrón F; IMMED S.L., Immunological and Medicinal Products, C/Velázquez 57, 6º derecha, 28001 Madrid, Spain.; Catapult Therapeutics, 8243 RC Lelystad, The Netherlands., Stein JV; Department of Oncology, Microbiology and Immunology, University of Fribourg, CH-1700 Freiburg, Switzerland., Muñoz-Calleja C; Immunology Department, Hospital Universitario de La Princesa, IIS-IP, 28006 Madrid, Spain.; School of Medicine, Universidad Autónoma de Madrid, 28029 Madrid, Spain., Cuesta-Mateos C; Immunology Department, Hospital Universitario de La Princesa, IIS-IP, 28006 Madrid, Spain.; IMMED S.L., Immunological and Medicinal Products, C/Velázquez 57, 6º derecha, 28001 Madrid, Spain.; Catapult Therapeutics, 8243 RC Lelystad, The Netherlands.
Publikováno v:
Cancers [Cancers (Basel)] 2022 May 31; Vol. 14 (11). Date of Electronic Publication: 2022 May 31.
Autor:
Loscertales, J., Ayarra Jarne, J., Congregado, M., Tristán, A. Arroyo, Merchán, R. Jiménez, Girón Arjona, J.C., Arenas Linares, C.
Publikováno v:
In Archivos de Bronconeumología (Internet) 2004 40(9):409-413